Free Trial
OTCMKTS:RNVA

Rennova Health (RNVA) Stock Price, News & Analysis

Rennova Health logo

About Rennova Health Stock (OTCMKTS:RNVA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
1.17 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rennova Health and its competitors with MarketBeat's FREE daily newsletter.

RNVA Stock News Headlines

Rennova Health Inc (RNVA)
RNVA Rennova Health, Inc.
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Rennova Health Inc RNVA
See More Headlines

RNVA Stock Analysis - Frequently Asked Questions

Rennova Health, Inc. (OTCMKTS:RNVA) released its quarterly earnings data on Tuesday, August, 14th. The company reported $2,500,000,000.00 earnings per share for the quarter. The firm earned $3.29 million during the quarter.

Rennova Health shares reverse split before market open on Wednesday, March 16th 2022.The 1-10000 reverse split was announced on Wednesday, March 16th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Shares of RNVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), LadRx (CYTR), NightHawk Biosciences (NHWK), Precipio (PRPO), 22nd Century Group (XXII) and Biopharmx (BPMX).

Company Calendar

Last Earnings
8/14/2018
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:RNVA
Previous Symbol
NASDAQ:RNVA
CIK
931059
Employees
60
Year Founded
1995

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$18.69 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
43,051,320,000
Free Float
34,350,651,000
Market Cap
$4.31 million
Optionable
Not Optionable
Beta
17.59

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:RNVA) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners